This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Zhihui Qiu: Innovator in Pharmaceutical Compositions
Introduction
Zhihui Qiu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for oral administration. His work is characterized by a focus on enhancing the efficacy and safety of pharmaceutical products.
Latest Patents
Zhihui Qiu holds 1 patent for a pharmaceutical composition that includes 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactate monohydrate. This composition is designed for oral administration and comprises specific ingredients such as fillers, disintegrants, and lubricants, which are carefully measured to optimize the overall effectiveness of the medication.
Career Highlights
Zhihui Qiu is currently employed at Novartis AG, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions that address various health challenges. His contributions have been instrumental in advancing the company's product offerings.
Collaborations
Zhihui Qiu collaborates with fellow researchers and professionals in the industry, including his coworker Jeewan Thakur. Together, they work on projects that aim to push the boundaries of pharmaceutical science and improve patient outcomes.
Conclusion
Zhihui Qiu is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions and dedication to improving healthcare. His work continues to impact the field positively, showcasing the importance of research and development in creating effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
